SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1205-1212

  Miyawaki, Akihiko ^a   Ikeda, Ryuji ^b   Hijioka, Hiroshi ^a   Ishida, Takayuki ^a   Ushiyama, Mina ^b   Nozoe, Etsuro ^a   Nakamura, Norifumi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

18F fluoro 2 deoxyglucose positron emission tomography; Glucose membrane transporter 1; Hypoxia inducible factor 1 ; Oral squamous cell carcinoma; Standardized uptake value; Vascular endothelial growth factor

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL STRAIN KB; CHEMOSENSITIVITY; CLINICAL ARTICLE; CYTOTOXICITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLUCOSE TRANSPORT; HISTOLOGY; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INHIBITORY CONCENTRATION 50; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950819425     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000751     Document Type: Article

References (30)

1. Shah NG, Trivedi TI, Rajen A, et al: Prognostic significance of molecular markers in oral squamous cell carcinoma: multivariable analysis. Head Neck 31: 1544-1556, 2009.
2. Uehara M, Sano K, Ikeda H, et al: Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to prognosis. Oral Oncol 45: 241-246, 2009.
3. Kitagawa Y, Sadato N, Azuma H, et al: FDG PET to evaluate combination intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med 40: 1132-1137, 1999. (Pubitemid 29315503)
4. Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, et al: Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT and 67 Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44: 198-206, 2003.
5. Brun E, Kjellen E, Tennvall J, et al: FDG-PET studies during treatment: Prediction of therapy outcome in head and neck squamous carcinoma. Head Neck 24: 127-135, 2002. (Pubitemid 34111509)
6. Swisher SG, Erasmus J, Maish M, et al: 2-Fluoro-2-deoxy-Dglucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101: 1776-1785, 2004. (Pubitemid 39314740)
7. Van Baardwijk A, Dooms C, van Suylen RJ, et al: The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1· and GLUT-1 in non-small cell lung cancer. Eur J Cancer 43: 1392-1398, 2007. (Pubitemid 46874072)
8. Li SJ, Guo W, Ren GX, Huang G, Chen T and Song SL: Expression of Glut-1 in primary and recurrent head & neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2- deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofac Surg 46: 180-186, 2008. (Pubitemid 351337627)
9. Lowe VJ, Dunphy FR, Varvares M, et al: Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 19: 666-674, 1997. (Pubitemid 27495306)
10. Kitagawa Y, Sano K, Nishizawa S, et al: FDG PET for prediction of tumor aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med 30: 63-71, 2003. (Pubitemid 36692894)
11. Lee SW, Nam SY, Im KC, et al: Prediction of prognosis using standardized uptake value of 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission tomography for nasopharyngeal carcinomas. Radiother Oncol 87: 211-216, 2008.
12. Harada H, Kizaka-Kondoh S, Li G, et al: Significance of HIF-1- active cells in angiogenesis and radioresistance. Oncogene 26: 7508-7516, 2007. (Pubitemid 350207705)
13. Song X, Liu X, Chi W, et al: Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1· gene. Cancer Chemother Pharmacol 58: 776-784, 2006. (Pubitemid 44351258)
14. Lin PY, Yu CH, Wang JT, et al: Expression of hypoxiainducible- 1· is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 37: 18-25, 2008. (Pubitemid 350264782)
15. Zhong H, De Marzo AM, Laughner E, et al: Overexpression of hypoxia-inducible-1· in common human cancer and their metastases. Cancer Res 59: 5830-5835, 1999.
16. Kim JW and Dang CV: Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66: 8927-8930, 2006.
17. Tian M, Zhang H, Nakasone Y, Mogi K and Endo K: Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Eur J Nucl Med Mol Imaging 31: 5-12, 2004. (Pubitemid 38133535)
18. Shimosato Y, Oboshi S and Baba K: Histological evaluation of effects of radiotherapy and chemotherapy for carcinoma. J Clin Oncol 1: 19-35, 1971.
19. Shibusa T, Shijubo N and Abe S: Tumor angiogenesis and vascular endothelial growth factor expression in stage 1 lung adenocarcinoma. Clin Cancer Res 4: 1483-1487, 1998. (Pubitemid 28265232)
20. Carmichael J, DeGraff WG, Gazdar AF, Minna J and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987. (Pubitemid 17027905)
21. Chen Z-S, Mutoh M, Sumizawa T, Furukawa T, et al: An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. Exp Cell Res 240: 312-320, 1998. (Pubitemid 28371112)
22. De Geus-Oei LF, van Krieken JH, Aliredjo RP, et al: Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 55: 79-87, 2007. (Pubitemid 46038871)
23. Kim MK, Ryu JS, Kim SB, et al: Value of complete metabolic response by 18F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy. Eur J Cancer 43: 1385-1392, 2007.
24. Higashi K, Ueda Y, Arisaka Y, et al: 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 43: 39-45, 2002. (Pubitemid 34101186)
25. Yamamoto E, Kohama G, Sunakawa H, Iwai M and Hiratsuka H: Mode of invasion, bleomycine sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer 51: 2175- 2180, 1983. (Pubitemid 13106840)
26. Kunkel M, Moergel M, Stockinger M, et al: Overexpression of Glut-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity. Oral Oncol 43: 796-803, 2007. (Pubitemid 47263526)
27. Cantuaria G, Magalhaes A, Penalver M, et al: Expression of GLUT-1 glucose transporter in borderline and malignant epithelial tumor of ovary. Gynecol Oncol 79: 33-37, 2000.
28. Mees G, Dierckx R, Vangestel C and Van de Wiele C: Molecular imaging of hypoxia with radiolabelled agents. Eur J Nucl Med Mol Imaging 36: 1674-1686, 2009.
29. Oriuchi N, Higashi T, Ishikita T, et al: Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci 97: 1291-1297, 2006. (Pubitemid 44614979)
30. Saga T, Koizumi M, Furukawa T, Yoshikawa K and Fujibayashi Y: Molecular imaging of cancer evaluating characters of individual cancer by PET/SPECT imaging. Cancer Sci 100: 375-381, 2009.